Global Probiotics in Animal Feed Market

1 INTRODUCTION OF GLOBAL PROBIOTICS IN ANIMAL FEEDMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PROBIOTICS IN ANIMAL FEEDMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PROBIOTICS IN ANIMAL FEEDMARKET, BY LIVESTOCK
5.1 Overview
5.2 Poultry
5.3 Swine
5.4 Cattle
5.5 Aquaculture
5.6 Others

6 GLOBAL PROBIOTICS IN ANIMAL FEED MARKET, BY FORM
6.1 Overview
6.2 Liquid
6.3 Dry

7 GLOBAL PROBIOTICS IN ANIMAL FEED MARKET, BY SOURCE
7.1 Overview
7.2 Bacteria
7.2.1 Lactobacilli
7.2.2 Streptococcus Thermophilus
7.2.3 Bifidobacteria
7.3 Yeast

8 GLOBAL PROBIOTICS IN ANIMAL FEED MARKET, BY FUNCTION
8.1 Overview
8.2 Gut Health
8.3 Nutrition
8.4 Immunity
8.5 Productivity
8.6 Carcass Yield

9 GLOBAL PROBIOTICS IN ANIMAL FEEDMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL PROBIOTICS IN ANIMAL FEEDMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Mitsui Co. Ltd.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Chr. Hansen
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Alltech
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Koninklijke DSM NV
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Evonik
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Lallemand
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Schouw& Co.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Lesaffre& CIE
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Land O' Lakes
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development

11.10 EI DuPont De Nemours and Company
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development

11.11 Calpis Co. Ltd
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development

11.12 Novozymes A/S
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Development

12 Appendix
12.1 Related Reports